Childhood Kidney Diseases

Korean Society of Pediatric Nephrology (대한소아신장학회)
권호 표지
DOI QR코드

DOI QR Code

How to treat recurrent focal segmental glomerulosclerosis after kidney transplantation in children

  • Peong Gang Park (Department of Pediatrics, Ajou University School of Medicine)
  • Received : 2024.12.12
  • Accepted : 2025.01.10
  • Published : 2025.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Focal segmental glomerulosclerosis (FSGS), a significant cause of kidney failure in children, is a common pathological diagnosis in cases of idiopathic nephrotic syndrome, especially steroid-resistant ones. FSGS has the potential to recur after kidney transplantation, often leading to graft loss. However, not all children with FSGS experience recurrence posttransplantation, such as those with genetic or secondary forms, which have minimal risk. Moreover, advancements in management, including intensive plasmapheresis and immunosuppressive therapies like rituximab, have increased remission rates in cases of recurrence. Identifying patients at high risk of recurrence, such as those with an initial treatment response or previous failed transplantation, is crucial. These children require close monitoring of proteinuria and prompt, intensive treatment upon recurrence to improve outcomes.

Keywords

References

  1. Park PG, Kang HG, Park E, Ahn YH, Choi HJ, Han KH, et al. Baseline characteristics of participants enrolled in the KoreaN cohort study for Outcomes in patients With Pediatric Chronic Kidney Disease (KNOW-Ped CKD). Pediatr Nephrol 2022;37:3177-87. https://doi.org/10.1007/s00467-021-05278-3
  2. Harambat J, van Stralen KJ, Kim JJ, Tizard EJ. Epidemiology of chronic kidney disease in children. Pediatr Nephrol 2012;27:363-73. https://doi.org/10.1007/s00467-011-1939-1
  3. Davin JC, Rutjes NW. Nephrotic syndrome in children: from bench to treatment. Int J Nephrol 2011;2011:372304.
  4. Alenazi SA. Incidence and pathological patterns of nephrotic syndrome among infants and children: a systematic review. Cureus 2024;16:e58331. https://doi.org/10.7759/cureus.58331
  5. Mahmoud I, Basuni F, Sabry A, El-Husseini A, Hassan N, Ahmad NS, et al. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis. Nephrol Dial Transplant 2005;20:735-42. https://doi.org/10.1093/ndt/gfh766
  6. Gohh RY, Yango AF, Morrissey PE, Monaco AP, Gautam A, Sharma M, et al. Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant 2005;5:2907-12. https://doi.org/10.1111/j.1600-6143.2005.01112.x
  7. Abbott KC, Sawyers ES, Oliver JD 3rd, Ko CW, Kirk AD, Welch PG, et al. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis 2001;37:366-73. https://doi.org/10.1053/ajkd.2001.21311
  8. Hariharan S, Adams MB, Brennan DC, Davis CL, First MR, Johnson CP, et al. Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation 1999;68:635-41. https://doi.org/10.1097/00007890-199909150-00007
  9. Ding WY, Koziell A, McCarthy HJ, Bierzynska A, Bhagavatula MK, Dudley JA, et al. Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence. J Am Soc Nephrol 2014;25:1342-8. https://doi.org/10.1681/ASN.2013080852
  10. Garrouste C, Canaud G, Buchler M, Rivalan J, Colosio C, Martinez F, et al. Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: clinical outcomes. Transplantation 2017;101:649-56. https://doi.org/10.1097/TP.0000000000001160
  11. Lanaret C, Anglicheau D, Audard V, Buchler M, Caillard S, Couzi L, et al. Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: results of a nationwide study. Am J Transplant 2021;21:3021-33. https://doi.org/10.1111/ajt.16504
  12. Pelletier JH, Kumar KR, Engen R, Bensimhon A, Varner JD, Rheault MN, et al. Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings. Pediatr Nephrol 2018;33:1773-80. https://doi.org/10.1007/s00467-018-3994-3
  13. Subramani V, Venkatasubramanian V, Sethi J, Sekar A, Patil SS, Kenwar DB, et al. Immediate recurrence of genetic focal segmental glomerulosclerosis postkidney transplant. Indian J Transplant 2024;18:207-9. https://doi.org/10.4103/ijot.ijot_128_23
  14. Ferreira da Mata G, Mansur JB, Riguetti MT, Rezende GF, Osmar de Medina Pestana J, Mastroianni Kirsztajn G. A single-center, retrospective study of focal segmental glomerulosclerosis after kidney transplantation: evolutive analysis. Int J Organ Transplant Med 2021;12:1-10.
  15. Vinai M, Waber P, Seikaly MG. Recurrence of focal segmental glomerulosclerosis in renal allograft: an in-depth review. Pediatr Transplant 2010;14:314-25. https://doi.org/10.1111/j.1399-3046.2009.01261.x
  16. Nehus EJ, Goebel JW, Succop PS, Abraham EC. Focal segmental glomerulosclerosis in children: multivariate analysis indicates that donor type does not alter recurrence risk. Transplantation 2013;96:550-4. https://doi.org/10.1097/TP.0b013e31829c2431
  17. Morello W, Puvinathan S, Puccio G, Ghiggeri GM, Dello Strologo L, Peruzzi L, et al. Post-transplant recurrence of steroid resistant nephrotic syndrome in children: the Italian experience. J Nephrol 2020;33:849-57. https://doi.org/10.1007/s40620-019-00660-9
  18. Mang J, Hennig L, Liefeldt L, Duerr M, Lehner LJ, Bichmann A, et al. Focal segmental glomerulosclerosis and recurrence in living donor recipients. Res Rep Urol 2021;13:495-9. https://doi.org/10.2147/RRU.S308994
  19. Francis A, Trnka P, McTaggart SJ. Long-term outcome of kidney transplantation in recipients with focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2016;11:2041-6. https://doi.org/10.2215/CJN.03060316
  20. Uffing A, Perez-Saez MJ, Mazzali M, Manfro RC, Bauer AC, de Sottomaior Drumond F, et al. Recurrence of FSGS after kidney transplantation in adults. Clin J Am Soc Nephrol 2020;15:247-56. https://doi.org/10.2215/CJN.08970719
  21. Shirai Y, Miura K, Ishizuka K, Ando T, Kanda S, Hashimoto J, et al. A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrence. Kidney Int 2024;105:608-17. https://doi.org/10.1016/j.kint.2023.11.022
  22. Batal I, Watts AJ, Gibier JB, Hamroun A, Top I, Provot F, et al. Pre-transplant anti-nephrin antibodies are specific predictors of recurrent diffuse podocytopathy in the kidney allograft. Kidney Int 2024;106:749-52. https://doi.org/10.1016/j.kint.2024.07.022
  23. Delville M, Sigdel TK, Wei C, Li J, Hsieh SC, Fornoni A, et al. A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation. Sci Transl Med 2014;6:256ra136. https://doi.org/10.1126/scitranslmed.3008538
  24. Weber LT, Tonshoff B, Grenda R, Bouts A, Topaloglu R, Gulhan B, et al. Clinical practice recommendations for recurrence of focal and segmental glomerulosclerosis/steroid-resistant nephrotic syndrome. Pediatr Transplant 2021;25:e13955. https://doi.org/10.1111/petr.13955
  25. Straatmann C, Kallash M, Killackey M, Iorember F, Aviles D, Bamgbola O, et al. Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients. Pediatr Transplant 2014;18:29-34. https://doi.org/10.1111/petr.12185
  26. Ohta T, Kawaguchi H, Hattori M, Komatsu Y, Akioka Y, Nagata M, et al. Effect of pre-and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children. Transplantation 2001;71:628-33. https://doi.org/10.1097/00007890-200103150-00008
  27. Belson A, Yorgin PD, Al-Uzri AY, Salvatierra O, Higgins J, Alexander SR. Long-term plasmapheresis and protein A column treatment of recurrent FSGS. Pediatr Nephrol 2001;16:985-9. https://doi.org/10.1007/s004670100008
  28. Canaud G, Dion D, Zuber J, Gubler MC, Sberro R, Thervet E, et al. Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS). Nephrol Dial Transplant 2010;25:1321-8. https://doi.org/10.1093/ndt/gfp500
  29. Raina R, Wang J, Sharma A, Chakraborty R. Extracorporeal therapies in the treatment of focal segmental glomerulosclerosis. Blood Purif 2020;49:513-23. https://doi.org/10.1159/000506277
  30. Shah L, Hooper DK, Okamura D, Wallace D, Moodalbail D, Gluck C, et al. LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients. Pediatr Nephrol 2019;34:2343-50. https://doi.org/10.1007/s00467-019-04296-6
  31. Grenda R, Jarmuzek W, Rubik J, Piatosa B, Prokurat S. Rituximab is not a "magic drug" in post-transplant recurrence of nephrotic syndrome. Eur J Pediatr 2016;175:1133-7. https://doi.org/10.1007/s00431-016-2747-1
  32. Solomon S, Zolotnitskaya A, Del Rio M. Ofatumumab in post-transplantation recurrence of focal segmental glomerulosclerosis in a child. Pediatr Transplant 2019;23:e13413. https://doi.org/10.1111/petr.13413
  33. Seeman T, Dusek J, Vondrak K, Janda J. Ramipril in the treatment of proteinuria in children after renal transplantation. Pediatr Transplant 2010;14:283-7. https://doi.org/10.1111/j.1399-3046.2009.01216.x
  34. Nathanson S, Cochat P, Andre JL, Guyot C, Loirat C, Nivet H, et al. Recurrence of nephrotic syndrome after renal transplantation: influence of increased immunosuppression. Pediatr Nephrol 2005;20:1801-4. https://doi.org/10.1007/s00467-005-2053-z
  35. Yu CC, Fornoni A, Weins A, Hakroush S, Maiguel D, Sageshima J, et al. Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med 2013;369:2416-23. https://doi.org/10.1056/NEJMoa1304572
  36. Leroy S, Guigonis V, Bruckner D, Emal-Aglae V, Deschenes G, Bensman A, et al. Successful anti-TNFalpha treatment in a child with posttransplant recurrent focal segmental glomerulosclerosis. Am J Transplant 2009;9:858-61. https://doi.org/10.1111/j.1600-6143.2009.02550.x
  37. Mittal T, Dedhia P, Roy-Chaudhury P, Abu Jawdeh BG, Mogilishetty G, Cuffy MC, et al. Complete remission of post-transplantation recurrence of focal segmental glomerulosclerosis with the use of adrenocorticotrophic hormone gel: case report. Transplant Proc 2015;47:2219-22. https://doi.org/10.1016/j.transproceed.2015.07.013
  38. Audard V, Kamar N, Sahali D, Cardeau-Desangles I, Homs S, Remy P, et al. Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation. Transpl Int 2012;25:e62-6. https://doi.org/10.1111/j.1432-2277.2012.01462.x
  39. Meyer TN, Thaiss F, Stahl RA. Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis. Transpl Int 2007;20:1066-71. https://doi.org/10.1111/j.1432-2277.2007.00562.x